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A b s t r A c t
Strong evidence has accumulated from epidemiological and observational studies for 
a close association between several different air pollutants and adverse health effects, 
particularly for the residents of metropolitan areas. Although our understanding of 
the pathophysiological mechanisms involved remains incomplete, there are abundant 
data which link short-term exposure to air pollution, due to high concentrations of 
particulate and gaseous matter, toxic metals and aldehydes, with a significant increase 
in acute cardiopulmonary mortality, particularly in certain high-risk subsets of the 
population and with an acute increase in hospital admissions for cardiovascular and 
pulmonary diseases. Furthermore, there is also convincing evidence that prolonged 
exposure to elevated levels of air pollutants is responsible for chronic ill effects that 
significantly reduce overall life expectancy. Thus, it is of paramount importance for 
regulatory agencies to force the implementation of relevant regulations and quality 
standards in order to protect the health of the population at large. Specific guidelines 
should also apply for activity restriction for vulnerable and high-risk persons, such 
as the very young and the elderly, and those with known cardiopulmonary disease or 
diabetes mellitus.
I N t r O D U c t I O N
According with the 2013 Update of Heart Disease and Stroke Statistics of the 
American Heart Association, mortality data showed that cardiovascular disease (CVD) 
as the listed underlying cause of death accounted for 32.3% of all deaths in 2009, or 
≈1 of every 3 deaths in the United States.1 CVD any-mentions constituted 54.6% of all 
deaths that year. On average, >2150 Americans die of CVD each day, an average of 
1 death every 40 seconds. CVD currently claims more lives each year than cancer and 
chronic lower respiratory disease combined. More importantly, CVD is rapidly becoming 
a major cause of death worldwide, and current projections indicate that between 1990 
and 2020, the proportion of worldwide deaths from CVD will increase from 28.9% 
to 36.3%.2 Traditional risk factors, comprising hypercholesterolemia, hypertension, 
smoking and diabetes as modifiable and age, gender and heredity as nonmodifiable 
risk factors, have been associated with the development of CVD, but a considerable 
percentage of patients afflicted by CVD have no established risk. Mechanisms of 
thrombosis and inflammation have been recently added to the predisposing risk factors,3 
however, we are still left with important determinants of CVD that currently remain 
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unknown.2 Furthermore, the development of CVD appears 
to be the result of an intricate interplay among genetic and 
environmental factors.4,5 With regards to the influence of the 
environment, it is only recently that the significant contribution 
of ambient pollutants to the development of CVD has begun 
to be appreciated.5 The cardiovascular, lung and other organ 
toxicity of pollutant exposure has been increasingly recognized. 
P A r t I c U l A t E  M A t t E r
In December 1952, a smog disaster occurred in London, 
with a subsequent substantial increase in mortality associated 
with the increase in air pollution.6 There was an alarming in-
crease in cardiovascular and respiratory deaths. The increase 
was greatest in the elderly. Hospital admissions were increased 
for both respiratory and cardiovascular diseases. In India, the 
worst civilian pollution crisis was the 1984 Bhopal Disaster.7 
Leaked industrial vapors from the Union Carbide factory killed 
more than 25,000 people and estimates for ensuing injuries 
vary anywhere from 150,000 to 500,000. To date, a plethora of 
studies have linked air pollution with daily mortality.5 Thus, the 
role of environmental pollutants in producing heart, lung and 
other organ diseases has begun to emerge and to be seriously 
discussed as a new risk factor.2,4,5,8-12
Common sources of air pollution include particulate mat-
ter (PM), ozone, nitrogen dioxide (NO2), and sulfur dioxide 
(SO2).5 Both indoor and outdoor air pollution have caused 
approximately 3.3 million deaths worldwide. Children aged <5 
years that live in developing countries are deemed the most 
vulnerable group. According to the World Health Organiza-
tion (WHO), 2.4 million people die each year from causes 
directly attributable to air pollution. Epidemiological studies 
suggest that more than 500,000 Americans die each year from 
cardiopulmonary disease related to breathing fine particle air 
pollutants. Worldwide more deaths per year are linked to air 
pollution than to motor vehicle accidents. A 2005 study by the 
European Commission calculated that air pollution reduces 
life expectancy by an average of ~9 months across the Euro-
pean Union (http://en.wikipedia.org/wiki/Air_pollutants).13 
Causes of deaths mainly relate to cardiopulmonary diseases.
The high susceptibility of cardiovascular tissues to environ-
mental pollutants is clearly underscored by a report indicating 
that the hearts of rats exposed to environmental tobacco smoke 
garner as many DNA adducts as the lung.14 However, while 
DNA lesions in the lung diminished upon discontinuation of 
exposure, no significant DNA repair could be noted in the 
myocardium, indicating a higher susceptibility of the heart 
to deleterious effects of environmental toxins.14 There is also 
strong evidence that exposure to ambient air particulate mat-
ter produces oxidative stress-induced DNA damage. Related 
biomarkers and individual exposure monitoring may be useful 
tools for risk stratification.15 
Besides tobacco smoke, other pollutants (particulate and 
gaseous matter, metals, aldehydes) have also been found to 
affect cardiovascular tissues. The most convincing data come 
from studies examining the effects of ambient particulate mat-
ter on heart disease and CVD mortality. These data indicate a 
link between the levels of air particulates and CVD, implying 
that pollutants can adversely affect the cardiovascular system. 
It has been demonstrated consistently that both respirable 
particles (<10 μm in diameter; particulate matter-PM10) and 
fine particles that reach the deep lung (<2.5 μm; PM2.5) increase 
mortality.2,5 The estimation is that each 10 μg/m3 elevation in the 
PM10 level increases the relative rate of death from all causes 
by 0.4–1% and each 10 μg/m3 increase in long-term average 
PM2.5 is associated with a 4% increased risk of all-cause mor-
tality and a 6% increased risk of cardiopulmonary mortality. 
Both PM10 and PM2.5 can reach the alveoli, while the ultrafine 
particles (<0.1 μm in diameter) can also pass into the systemic 
circulation and cause extrapulmonary toxicity.
Several studies have shown that increased PM10 and PM2.5 
concentrations are associated with an increase in cardiovascular 
hospital admissions due to both ischemic heart disease and 
congestive heart failure.2 Exposure to elevated PM2.5 levels 
have also been linked to a temporal (within a few hours and 1 
day) triggering of acute myocardial infarction (MI).16 There 
are reports of air pollution causing an increase in heart rate, 
reduction of heart rate variability and an increase in the inci-
dence of cardiac arrhythmias.17,18 A likely explanation may be 
related to a cumulative multifactorial effect of particulates on 
hemostatic, vasoconstrictive, and autonomic factors leading to 
increased electrical instability and triggering of acute coronary 
syndromes in a susceptible population.2 In addition to trigger-
ing of acute events, PM exposure can also induce chronic and 
sustained cardiovascular damage, such as an increase in ath-
erosclerosis and vulnerable atherosclerotic plaque formation, 
chronic inflammation and thrombogenesis, all contributing to 
increased cardiovascular mortality (Fig. 1).4,5,19 
Systemic inflammation markers (interleukin 6 /IL-6, fibrino-
gen, and C-reactive protein) were correlated with concurrent 
levels of air pollution in a prospective longitudinal study of 
1,003 MI survivors, performed in 6 European cities (2003 – 
2004).19 The investigators collected hourly data on particle 
number concentrations, mass concentrations of particulate 
matter (PM) <10 μm (PM10) and <2.5 μm (PM2.5), gaseous 
pollutants, and meteorological data at central monitoring sites 
in each city. Pooled results showed an increase in IL-6 when 
particle number concentrations were elevated 12–17 h before 
blood withdrawal (% change of geometric mean, 2.7). Five-day 
cumulative exposure to PM10 was associated with increased 
fibrinogen concentrations (% change of arithmetic mean, 0.6). 
Results remained stable for smokers, diabetics, and patients 
with heart failure. The authors concluded that their results 
might provide a link between air pollution and adverse cardiac 
events, as they observed an immediate thrombo-inflammatory 
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FIgUrE 1. Possible pathophysiology of air-pollutant ill effects (focus on CVD). CV = cardiovascular; CVD = cardiovascular dis-
ease; DCM = dilated cardiomyopathy; GI = gastrointestinal; HF = heart failure; HR = heart rate; HRV = heart rate variability; 
HTN = hypertension; LVH = left ventricular hypertrophy; MI = myocardial infarction; RD = respiratory disease; ROS = reactive 
oxygen species; SCD = sudden cardiac death; VEA = ventricular ectopic activity.
response to particle number concentrations as reflected by 
increased IL-6 and fibrinogen levels. 19 
A study examined the association between air pollution 
and cardiovascular hospital admissions for persons aged 65 
years and older in the Detroit, Michigan, metropolitan area 
during the years 1986–1989.8 Particulate matter with an aero-
diameter of ≤10 μm (PM10) was associated with daily admis-
sions for ischemic heart disease (relative risk-RR = 1.018, 
for an interquartile range (32 μg/m3) increase in pollution). 
SO2, CO, and ozone made no independent contribution to 
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ischemic heart disease admissions. Both PM10 (RR = 1.024) 
and CO (RR = 1.022, for an interquartile range (1.28 ppm) 
increase in pollution) showed independent associations with 
heart failure admissions. 8 
In a prospective cohort study (Multi-Ethnic Study of Ath-
erosclerosis - MESA), investigators examined the associations 
between the progression of the intima-medial thickness (IMT) 
of the common carotid artery, as an indicator of atherosclerosis, 
and long-term PM2.5 concentrations among 5,362 participants 
completing two ultrasound examinations.20 The authors found 
that among persons with a mean annual progression of 14 
μm/y, 2.5 μg/m3 higher levels of residential PM2.5 during a 2.5-
year follow-up period were associated with 5.0 μm/y greater 
IMT progressions among persons in the same metropolitan 
area. Although significant associations were not found with 
IMT progression without adjustment for metropolitan area 
(0.4 μm/y per 2.5 μg/m3), all of the 6 areas showed positive 
associations. Greater reductions in PM2.5 over follow-up for 
a fixed baseline PM2.5 were also associated with slowed IMT 
progression (22.8 μm/y per 1 μg/m3 reduction). The authors 
concluded that higher long-term PM2.5 concentrations are 
associated with accelerated atherosclerosis as indicated by 
increased IMT progression and that greater reductions in 
PM2.5 are related to slower IMT progression.20 
In a study analyzing data obtained from the American Can-
cer Society, the risk factor data for approximately half a million 
adults were linked with air pollution data for metropolitan areas 
throughout the USA and combined with vital status and cause 
of death data through the year 1998.10 The results indicated 
that fine particulate and sulfur oxide–related pollution were 
associated with all cause, lung cancer, and cardiopulmonary 
mortality. Each 10-μg/m3 elevation in fine particulate air pol-
lution was associated with approximately a 4%, 6%, and 8% 
increased risk of all-cause, cardiopulmonary, and lung cancer 
mortality, respectively. The authors concluded that long-term 
exposure to combustion-related fine particulate air pollution 
is an important environmental risk factor for cardiopulmonary 
and lung cancer mortality.
O t H E r  A I r  P O l l U t A N t s
The composition of air particulates is variable and depends 
on geographic location, season, local climate, presence of in-
dustrial compounds, and traffic status. Particulates consist of 
products of combustion, airborne material from the earth crust, 
biological material (pollen, bacteria, viruses, and endotoxins), 
metals (e.g., Fe, V, Ni, Cu, Zn, Pb, Mn), inorganic compounds 
(oxides, nitrates, and sulfates), polyaromatic hydrocarbons, 
ethers, amines, nitriles, carboxylic acids and aldehydes .
M E t A l  t O x I c I t y
Toxic metals contained in the inhaled particulate matter can 
be transported to many extrapulmonary sites where they may 
generate reactive oxygen species and induce oxidative stress. 
Toxicity has been ascribed to vanadium (V), nickel (Ni), copper 
(Cu), iron (Fe), and zinc (Zn). Chromium (Cr), mercury (Hg), 
and cadmium (Cd) contained in particulate matter are also 
deemed toxic as studies show that environmental exposure to 
these metals results in their deposition in the heart and blood 
vessels, and that the cardiovascular tissues are significant 
targets of metal toxicity.2
The European community has issued regulations for the 
emissions of elements of highest concern which include arsenic, 
cadmium, cobalt, chromium, copper, mercury, manganese, 
nickel, lead, tin, and thallium. Minute amounts of some of these 
elements are necessary for humans (cobalt, copper, chromium, 
manganese, nickel) but toxic in larger concentrations, while 
others are carcinogenic or toxic to several systems, e.g. central 
nervous system (manganese, mercury, lead, arsenic), kidneys or 
liver (mercury, lead, cadmium, copper), skin, bones, or teeth 
(nickel, cadmium, copper, chromium). Heavy metal pollu-
tion most commonly arises from the purification of metals or 
electroplating. Rubber tires on road surfaces release cadmium, 
lead and zinc in tiny particulates as dust. 
Exposure to cadmium is associated with arterial hyperten-
sion and increased aortic resistance.2 Furthermore, an increase 
in the incidence of heart failure in Japanese inhabitants of an 
area polluted by cadmium has been reported.21 Long-term 
arsenic exposure is associated with peripheral vascular dis-
ease and with an increase in the incidence of ischemic heart 
disease.22 Interestingly, marked increases in myocardial trace 
element concentration have been observed in cases of idiopathic 
dilated cardiomyopathy.23 These observations underscore the 
association of metal pollutants in air particulates or drinking 
water with CVD risk.
g A s E O U s  P O l l U t A N t s
Sulfur and nitrogen oxides are emitted into the atmosphere 
primarily from the burning of fossil fuels. Thus, air pollut-
ants are produced in the form of particulate matter (sulfates, 
nitrates) and related gases (nitrogen dioxide-NO2, sulfur 
dioxide-SO2 and nitric acid). Nitrogen oxides also will interact 
with volatile organic compounds to form ozone (http://www.
epa.gov/oar/aqtrnd99/chapter7.pdf).24 Atmospheric carbon 
monoxide (CO) and nitrogen dioxide (NO2) levels have been 
shown to be associated with hospital admissions for ischemic 
heart disease and with an increased risk of inducible ischemia at 
exercise tests in patients with stable coronary artery disease.2,5 
Increased risk of cardiovascular morbidity and mortality on CO 
or SO2 exposure has been documented by several epidemiologi-
cal studies.25,26 Ozone is an additional copollutant, which can 
induce pulmonary inflammation and edema, or may confer a 
bradycardic effect. 
A French study (AMI registry - the Toulouse MONICA 
Project) examined the relationship between short-term expo-
AIR POLLUTION
107
sure to air pollutants and the occurrence of acute MI (1997-
1999) in individuals 35 to 64 years of age by measuring hourly 
concentrations of SO2, NO2, and O3.27 After adjustment for 
temperature, relative humidity, and influenza epidemics, the 
relative risks (RRs) (for an increase of 5 μg/m3 of O3 con-
centration) for acute MI occurrence were significant for the 
current-day and 1-day-lag measurements (RR, 1.05; P=0.009; 
and RR, 1.05; 95% CI, 1.01 to 1.09; P=0.007, respectively). 
Individuals 55 - 64 years of age with no prior history of ischemic 
heart disease were the most susceptible to develop an acute 
MI (RR, 1.14). NO2 and SO2 exposures were not significantly 
associated with the occurrence of acute MI. The authors con-
cluded that observational data confirm that short-term ozone 
exposure within a period of 1 to 2 days is related to acute MI 
in middle-aged adults without previous heart disease, whereas 
NO2 and SO2 are not.27
On the other hand, Bell et al indicated that the gaseous 
pollutants NO2 and CO are exhibiting the strongest and most 
consistent associations with emergency department visits.11 
Similarly, Forastiere et al have examined the association 
between hospital admissions in Rome related to coronary 
disease and ambient air pollution including CO, NO2, PM, and 
ultrafine particles. They found the strongest associations for 
CO and ultrafine particle concentrations for fatal and nonfatal 
hospitalization for acute MI.12 Finally, during a follow-up of 
MI survivors in 5 European cities, all pollutants, including 
CO, NO2, PM, and ultrafine particles, were associated with 
increased risk of hospital readmissions.9
A l D E H y D E s
Several aldehydes such as crotonaldehyde, glyoxal, glycoal-
dehyde, and hydroxybenzaldehde are important constituents 
of PM2.5, and are considered responsible for mediating car-
diotoxicity. Other volatile aldehydes may be PM copollutants.
Aldehydes are present in high concentrations in automobile 
exhaust and smog and are generated during combustion of or-
ganic material in any form (coal, wood, paper, or cotton). They 
constitute 1 - 2% of the volatiles generated from automobile 
exhaust and the burning of fossil fuels. Cigarette smoke con-
tains 50–70 parts/million acrolein, and 0.04– 2.2 parts/million 
acrolein has been detected near petrochemical plants. In ad-
dition, acrolein and related aldehydes are also present in high 
abundance in several food substances, and their concentration 
is particularly high in fried foods and reheated oils. With the 
exception of metals, aldehydes are the major toxic substances 
in drinking water. Over 36 different aldehydes are found in 
drinking water, of which acrolein and endrin have been clas-
sified as the two highest priority pollutants. 
Strong evidence suggests that aldehydes may confer adverse 
cardiovascular effects.2 Direct exposure to high concentra-
tions of unsaturated aldehydes is cardiotoxic. They may be 
arrhythmogenic by causing prolongation of the Q-T interval, 
and may elicit vasopressor and hypertensive effects. Chronic 
changes in cardiovascular tissues on aldehyde exposure may 
lead to cardiac hypertrophy, hypercholesterolemia and plaque 
formation. Occupational exposure to aldehydes could also in-
duce cardiovascular changes. Increased risk of atherosclerotic 
heart disease has been reported in plant workers producing 
formaldehyde, as well as a higher incidence of heart disease 
in undertakers, embalmers, and perfumery workers, all linked 
to aldehyde exposure. Finally, the high concentration of al-
dehydes in cigarette smoke raises the possibility that some of 
the adverse cardiovascular effects of smoking are related to 
aldehyde toxicity. 
In addition to direct exposure to aldehydes, exposure to 
industrial pollutants that generate aldehydes has also been 
linked to an increased risk of cardiovascular disease. Exposure 
to 1,3-butadiene is associated with an increased incidence of 
atherosclerosis, particularly in workers exposed to butadiene 
in styrene-butadiene rubber polymer manufacturing plants. 
Similar increases in CVD risk have been suggested for workers 
exposed to vinyl chloride, which is metabolized via cytochrome 
P450 to its active constituent, chloroaldehyde. A 7-year study 
of 1,100 workers exposed to vinyl chloride monomer showed 
a significant increase in cardiovascular diseases, including 
hypertension, MI, and other circulatory disorders.28 
s t y r E N E  E x P O s U r E
Epidemiologic studies have reported increased daily mor-
tality and hospital admissions associated with exposure to 
particulate air pollution. Cardiovascular deaths constitute 
large part of this increased mortality. However, the reason 
behind this detrimental effect of air dust is not clear. It has 
been suggested that some substances adhering to particulates 
could be responsible for acute cardiovascular effects. Styrene, a 
volatile hydrocarbon (also known as vinyl benzene and phenyl 
ethane), the precursor to polystyrene and several copolymers, 
has been incriminated as such a deleterious substance. Sty-
rene is widespread in ambient air emanating from industrial 
sources, exhaust gases of various engines, and smoke of fossil 
fuel combustion to name a few. Styrene concentrations may 
vary significantly [0.40 to 3.80 μg/m3 (0.09–0.89 ppb)], reach-
ing levels of 2,934 μg/m3 in ambient air in communities near 
some industrial sources. Some believe that this range may be 
underestimated for a variety of reasons. For example, only 
the vaporous part is measured, while the aerosol form or 
that adhered to suspended particulates is not included as air 
samples for styrene use charcoal tube collection or passive 
dosimeters; styrene aerosols could also undergo physical and 
chemical alteration, such as vaporization and/or polymerization 
and if vaporization occurs after inhalation, the result would 
be a highly concentrated vaporous dose to the respiratory 
system. Finally, styrene is a highly volatile hydrocarbon, which 
is rapidly transformed in the atmosphere through a reaction 
with hydroxyl radicals. The half-life for styrene in the atmo-
sphere is ~7 hours. Thus, styrene is not expected to undergo 
108
HOSPITAL CHRONICLES 8(3), 2013
extensive transportation, suggesting that styrene measured at 
scattered air-monitoring stations might not represent the high 
concentrations in the limits around styrene-emitting sources.
Styrene is highly lipophilic. Inhaled styrene is almost com-
pletely absorbed, rapidly dispersed throughout the body, and 
then degraded through oxidation of the side chain to soluble 
metabolites for final excretion. Industrial studies have found 
an increase in cardiovascular disease among styrene-exposed 
workers. A case-cohort study comprising 498 cases that died 
of ischemic heart disease explored a possible dose-response 
relation between styrene exposure and ischemic heart disease; 
the study also included 997 male workers employed during 
1943–1984 in two styrene-butadiene rubber-manufacturing 
plants in the United States. 29 The study showed that recent 
styrene exposure was significantly associated with acute isch-
emic heart disease death among active workers. The relative 
hazard of death from acute ischemic heart disease for exposure 
during the most recent 2 years among active workers with 2 or 
more years of employment was 2.95 at a time-weighted styrene 
concentration of 0.2–<0.3 ppm and 4.30 at ≥0.3 ppm for the 
same exposure period, respectively.29 Thus, the results of this 
study suggested that a chemical, like styrene, found in the air 
and in industrial settings, capable of getting absorbed onto 
particles, can be associated with an increased risk of heart 
disease precipitating acute cardiac events at relatively low 
industrial exposures. 
c l I N I c A l  E F F E c t s
With regards to the health effects of exposure to air pol-
lutants (Table 1), a few additional points need to be reviewed 
(http://www.csun.edu/~vchsc00b/468/).30 
Air pollution particulates are distinguished between inhal-
able, respirable, and thoracic particulate matter (PM). Inhal-
able particulate matter includes particles that enter the upper 
airways. Thoracic particles enter the airways and gas exchange 
regions of the lungs; respirable particles are a subset of thoracic 
particles that have a high probability of being deposited in 
lung tissue. The smaller the particle size, the more likely it 
will be deposited in lung tissue where adverse effects may oc-
cur. Ultrafine particles are particularly harmful to lung tissue. 
Short-term high-level exposure to air pollutants results 
in acute health effects with symptoms of eye, nose and throat 
irritation and/or asthmatic attacks usually experienced within 
hours. Extreme episodes may even result in death. Chronic 
effects result from low-level, long-term exposures, with disease 
syndromes developing several decades later; these may include 
respiratory and cardiovascular disease, neurotoxic effects and 
cancer. Groups that are more susceptible comprise very young 
or aged individuals, patients with pre-existing respiratory and/
or cardiovascular disease, occupationally exposed individuals 
diabetics and smokers. 
Target organs for air pollutant exposure include the eye, the 
skin, the respiratory and cardiovascular systems, the nervous 
system, and the gastrointestinal and reproductive systems. Ac-
rolein (propenal; an unsaturated aldehyde), formaldehyde and 
peroxyacetyl nitrate (PAN) are examples of common ambient 
irritants for the eye. Carbon monoxide (CO), lead and fine 
particles are primary pollutant candidates for cardiovascular 
toxicity. Carbon monoxide binds to hemoglobin to form car-
boxyhemoglobin which cannot release oxygen to the tissues. 
tAblE 1. Health Effects of Air Pollution
short-term Effects
Irritation to the eyes, nose and throat
Respiratory infections
 Bronchitis
 Pneumonia
Other symptoms
 Headache
 Nausea
 Allergic reactions
Exacerbation of medical conditions
 Asthma
 Bronchitis
 Emphysema
Triggering of 
 Acute myocardial infarction
 Stroke
 Arrhythmias
long-term Effects
Chronic respiratory disease
Cardiovascular disease
 Atherosclerosis
 Hypertension
 Heart failure
 Arrhythmias
 Prothrombotic state
Lung cancer
Other organ damage
 Brain
 Nerves
 Liver
 Kidney
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Exposure to carbon monoxide (CO) may also result in central 
nervous system effects. There is evidence to indicate that CO 
exposures can contribute to heart disease, increase the risk of 
heart attack and premature mortality. Lead has myriad harm-
ful effects, such as forming reactive radicals that damage the 
DNA, producing an inflammatory reaction, interfering with the 
immune system, causing anemia, hypertension, renal damage, 
neurotoxicity and so on. More specifically, lead is linked to CVD 
by promoting oxidative stress and inflammation, disrupting ni-
tric oxide (NO) signaling pathways, altering vasoregulation and 
endothelial function, inhibiting fibrinolysis, and contributing 
to the development of hypertension.31,32 Thus, with regards to 
lead exposure, the recommended threshold for lead blood level 
to avoid health effects, e.g., hypertension, is <7 μg/dl, while 
the concern level in children is >10 μg/dl. The Environmental 
Protection Agency (EPA) of the US has set a level of 0.15 μg/
m3 for lead in ambient air which is not to be exceeded (http://
www.epa.gov/air/criteria.html).33 The EPA has set National 
Ambient Air Quality Standards for 6 principal pollutants, 
which are called “criteria” pollutants and in addition to lead 
include CO, NO2, O3, SO2 and particle pollution PM2.5 and 
PM10 (Table 2). As aforementioned, premature cardiovascular 
mortality has been strongly associated with exposure to PM2.5. 
In a case-crossover design study, the authors examined the 
association between ambient air pollution and 798 confirmed 
ventricular arrhythmias in 84 subjects among 203 patients with 
implantable cardioverter defibrillators. The authors found 
that interquartile range increases in 24-hour moving average 
PM2.5 and ozone were independently associated with 19% and 
21% increased risks of ventricular arrhythmia, respectively.34 
The respiratory system has defense mechanisms that protect 
it from airborne particles. Nasal hairs prevent the passage of 
large particles into the respiratory system. Large particles are 
removed in the nasal turbinates and cleared from respiratory 
airways by the cilia-mucus escalator or by the cough/sneeze 
reflex. Small particles deposited in bronchioles and alveoli 
are removed by macrophages and the cilia-mucus escalator. 
However, very small particles can reach the alveoli and then 
transported to extrapulmonary organs and tissues. Exposure 
to air pollutants such as SO2, O3, and particles can result in 
tAblE 2. Air Quality Standards: Guideline Upper Values for Air Pollutants
Pollutant
WHO guidelines European Union Directive EPA standards
short-term 
Exposures
long-term 
Exposures
short-term  
Exposures
long-term 
Exposures
short-term  
Exposures
long-term 
Exposures
PM2.5 25 μg/m3
24-hour mean
10 μg/m3
annual mean 
25 μg/m3 (by 2015)
20 μg/m3 (by 2020)
annual mean 
35 μg/m3
24-hour mean
12 μg/m3
annual mean
PM10 50 μg/m3
24-hour mean
20 μg/m3
annual mean 
50 μg/m3
1-day mean
40 μg/m3
annual mean
150 μg/m3
24-hour mean
O3 100 μg/m3
8-hour mean
120 μg/m3
Maximum daily
8-hour mean
0.075 ppm
8-hour mean
NO2 200 μg/m3
1-hour mean
40 μg/m3
annual mean
200 μg/m3
1-hour mean
40 μg/m3
annual mean
100 ppb
1-hour mean
53 ppb
Annual mean
sO2 500 μg/m3
10-minute mean
20 μg/m3
24-hour mean
350 μg/m3
1-hour mean
125 μg/m3
1-day mean
75 ppb
1-hour mean
0.5 ppm
3-hour mean
benzene 5 μg/m3
annual mean
cO 10 mg/m3
max daily 8-h mean
35 ppm
1-hour mean
9 ppm
8-h mean
lead 0.5 μg/m3
annual mean
0.15 μg/m3
Rolling 3 month 
average
CO = carbon monoxide; EPA = Environmental Protection Agency (US); NO2 = nitrogen dioxide; O3 = ozone; PM = particulate matter; PM2.5, 
particulate matter <2.5 μm in aerodynamic diameter; PM10, particulate matter <10 μm in aerodynamic diameter; ppb = parts-per-billion; ppm = 
parts per million; SO2 = sulfur dioxide; WHO = World Health Organization
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asthmatic attacks. Certain air pollutants can increase the sever-
ity of infectious respiratory disease or increase the probability 
that infection may develop. Exposure to SO2 and acid sulfates 
can cause severe irritation of the upper airways. Apart from 
asthmatic attacks, exposure to SO2 can contribute to chronic 
bronchitis. Chronic bronchitis is a progressive disease of the 
respiratory airways caused by exposure to harmful substances 
in tobacco smoke and ambient pollution, leading to chronic 
inflammation, excessive mucus production, and decreased 
ciliary activity. Finally, long-term exposures to ozone (O3) 
may decrease lung elasticity. It also appears to cause asthmatic 
attacks, interfere with the body’s ability to defend itself from 
infection, and increase the risk of premature mortality. 
Most evidence to support a causal relationship between 
exposure to atmospheric pollutants and the development of 
lung cancer in humans is indirect. It includes higher rates of 
cancer in urban non-smokers, higher rates of cancer in migrants 
from high-pollution areas, etc. Recent epidemiological evidence 
shows a direct link with exposures to fine particles. A very large 
percentage of regulated “hazardous” or “toxic” pollutants are 
known or suspected human carcinogens. Asbestos is regulated 
as a hazardous air pollutant as it causes human cancer and 
there is no known safe level of exposure. 
The risk of disease from exposure to ambient air pollutants 
compared to tobacco smoking is relatively small from a public 
health standpoint, but it applies to the entire population with 
considerable public burden. Importantly, ambient air pollutant 
exposure and secondhand smoking constitute an involuntary 
risk and thus more likely to be regulated than voluntary risks 
(e.g., active smoking). Interestingly, banishment of smoking 
in public places in Europe has had significant effects on hos-
pital admissions for cardiovascular disease and in particular 
for coronary artery disease.35,36 The benefit was noted both in 
smokers and non-smokers, indicating that part of the adverse 
effects of secondhand smoke may be conferred via exposure to 
particulate matter indoors and outdoors.37 Indeed, pathophysi-
ological mechanisms linking active and secondhand smoking, 
as well as ambient air pollution with cardiovascular diseases 
are impressively similar.37,38
c O N c l U s I O N
There is strong emerging evidence that both indoor and 
outdoor air quality is a modifiable risk factor for cardiovas-
cular, pulmonary and other organ diseases, particularly for 
the residents of metropolitan areas. Air pollutants, including 
particulate and gaseous matter, metals and aldehydes, have 
serious health effects. Apparently, health effects of air pollution 
and even those of low-dose smoking and secondhand smoke, 
are still underestimated by decision makers around the world. 
Regulation of air quality needs sustained vigilance aiming at 
improving life expectancy. Current recommendations from the 
World Health organization (WHO) (global update 2005 on 
Air quality guidelines),39 the European Union (EU) (Directive 
2008)40 and the US Environmental Protection Agency (EPA) 
(National Ambient Air Quality Standards 2011)33 are outline 
in Table 2. It is of utmost importance for regulatory agencies 
to force the implementation of these regulations and maintain 
regularly monitored and updated quality standards in order to 
protect the health of the population at large. Specific atten-
tion should be given for activity restriction by susceptible and 
high-risk individuals, such as the very young and the elderly, 
and those with known cardiovascular and/or pulmonary disease 
or diabetes mellitus. 
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